Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208884 · ClinicalTrials.gov registry record
Terminal Graft Failure
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 19
- Enrollment target
NCT00208884 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 19 participants.
The verdict
NCT00208884 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
One of the risks associated with heart transplantation is failure of the graft. A graft is where the new heart is attached to the original vessels in the body. Approximately 10% of children suffer graft failure which, leads to heart failure and possible death. The problem is that we do not know some of the causes of graft failure thus, it is difficult to diagnose early and treat. Due to graft failure, lots of children are placed back on the transplant list and receive another new heart. In this study, we plan to perform a retrospective chart review looking to see if we can correlate graft failure with a problem with the vessels called coronary allograft vasculopathy or rejection. In order to do this, we will collect data from patient's charts that have been diagnosed with graft failure and compare their clinical presentation/data to pathology reports of the explanted hearts from these children. Explanted hearts are the old transplanted hearts that are removed in order to put a new heart into the body. Explanted hearts at our institution are always sent to pathology for analysis thus it will be quite easy to perform this review.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2003-10 |
| Est. Completion | 2005-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208884
The ClinicalTrials.gov registry entry for NCT00208884 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00208884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208884 about?
NCT00208884 is a clinical study titled "Terminal Graft Failure". One of the risks associated with heart transplantation is failure of the graft. A graft is where the new heart is attached to the original vessels in the body. Approximately 10% of children suffer graft failure which, leads to heart failure and possible death. The problem is that we do not know some...
What is the current status of trial NCT00208884?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2003-10. Estimated completion is 2005-11.
Who is sponsoring clinical trial NCT00208884?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.